Neurological manifestations in autoinflammatory syndromes: a series of 131 patients from our neuroimmunology departement by unknown
POSTER PRESENTATION Open Access
Neurological manifestations in autoinflammatory
syndromes: a series of 131 patients from our
neuroimmunology departement
E Schuh1*, P Lohse1,2, J Havla1, I Meinl1, L-A Gerdes1, R Hohlfeld1, T Kümpfel1
From 8th International Congress of Familial Mediterranean Fever and Systemic Autoinflammatory Diseases
Dresden, Germany. 30 September - 3 October 2015
Introduction
Cryopyrin-associated periodic syndrome (CAPS), familial
mediterranean fever (FMF) and tumor necrosis factor
receptor-associated periodic syndromes (TRAPS) are
rare systemic, monogenetic inherited autoinflammatory
diseases. The clinical significance of low penetrance
mutations in TRAPS and CAPS as well as heterozygosity
in FMF is still under debate. The frequency and clinical
pattern of peripheral and central nervous system (CNS)
manifestation in those patients remain unclear.
Objective/methods
To describe the neurological phenotype of patients with
a low penetrance variant in the TNFRSF1A gene, the
NLRP3 gene, or with a heterozygous mutation in the
MEFV gene seen in our neuroimmunology department
between 2006 and 2015.
Results
131 patients (f=88, m=43; mean age 41 ± 10 years) have
been identified in our outpatient clinic: 65 with a low
penetrance mutation in the TNFRSF1A gene, 23 with a
low penetrance variants in the NLRP3 gene and 43 with
a heterozygous mutation in the MEFV gene. 90 patients
had an additional diagnosis of multiple sclerosis (MS).
Headache and chronic pain syndromes were observed
among TRAPS, CAPS and FMF patients. Inflammation
predominately affected the eye and optic nerve. Other-
wise the neurological phenotype was heterogeneous
among groups and included mostly dysesthesia in
TRAPS patients, cranial nerve (CN) affection in CAPS
patients and CNS vasculitis in the FMF non-MS cohort.
Other systemic symptoms included abdominal pain,
arthralgias and myalgias, urticarial rash and severe fati-
gue. So far none of the patients had developed AA
amyloidosis.
Conclusion
In this large mono-centric cohort of patients with auto-
inflammatory syndromes concomitant MS was fre-
quently observed indicating that mutations in the
TNFRSF1A, NLRP3 and MEFV gene may contribute to
MS susceptibility. Besides MS a variety of neurological
manifestations can occur and TRAPS, CAPS and FMF
should be included as differential diagnosis in patients
with unusual CNS inflammation including CN affection,
severe headache syndromes and additional systemic
symptoms such as abdominal pain, arthralgia and urti-
carial rash suggestive for an autoinflammatory disease.
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